Baxter’s Colleague Consent Decree Enjoins Sales, Expands Obligations
This article was originally published in The Gray Sheet
Executive Summary
Baxter signed a consent decree with FDA June 29 forbidding the sale of its widely used but malfunction-prone Colleague intravenous infusion pump until the firm complies with manufacturing quality regulations